全球骨质密度检测设备市场规模（按技术、最终用户、区域范围和预测）

骨质密度检测设备市场规模及预测

2024 年骨质密度检测设备市场规模为 2.848 亿美元，预计到 2032 年将达到 3.9848 亿美元，2026 年至 2032 年的复合年增长率为 4.73%。

骨质密度检测设备是用来测量骨骼密度（BMD）的专用医疗设备，骨矿物质密度反映的是单位体积骨骼中的矿物质含量（主要是钙）。

双能吸收测量仪(DXA) 使用两束不同能量的低剂量X射线。骨组织对射线的吸收方式与软组织不同，因此可以精确测量骨密度 (BMD)。

骨质密度检测设备主要用于诊断骨质疏鬆症（其特征是骨密度低和骨折风险增加），监测骨质疏鬆症治疗的有效性并评估骨质疏鬆症人群的骨折风险。

在骨骼密度扫描过程中，患者需躺在检查台上，扫描臂会扫过被检查的身体特定部位。该过程无创且无痛，大约需要10到30分钟，具体取决于扫描区域的数量。

骨骼密度检测的常见部位是脊椎（腰椎）、髋部（股骨颈及整个髋关节）和前臂（桡骨）。之所以选择这些部位，是因为它们容易发生骨质疏鬆性骨折，并且能够提供准确的骨骼密度测量。

骨骼密度测试通常用于骨质疏鬆症风险较高的停经后妇女、老年人，以评估整体骨骼健康和骨折风险，以及患有某些疾病或服用影响骨骼密度的药物的人。

全球骨质密度检测设备市场动态

影响全球骨质密度检测设备市场的关键市场动态是：

关键市场驱动因素

骨质疏鬆症盛行率不断上升：骨质疏鬆症是一个严重的健康问题，尤其对老年人而言。随着世界人口老化，骨质疏鬆症及相关骨骼疾病的盛行率不断上升，这推动了对骨质密度检测设备进行早期诊断和监测的需求。

技术发展：随着骨骼密度测量技术的发展，例如便携式高解析度设备的出现，骨骼密度测试的准确性和效率正在不断提高。这些技术进步吸引了医疗保健提供者，促使他们投资新设备，从而带动医疗保健产业蓬勃发展。

提升认知度和筛检项目：随着人们对骨骼健康的认识不断提高，以及早期发现骨骼问题的重要性日益凸显，骨骼密度筛检的需求也随之增长。政府计画、健康宣传活动以及病患教育的不断完善，也推动了骨质密度检测设备在预防保健中的应用。

老年人口不断增长：骨质疏鬆症和骨质缺乏症是两种与骨骼相关的疾病，在老龄化社会中日益普遍。随着世界人口老化，对用于评估和管理老年人骨骼健康的骨骼密度测量工具的需求日益增长。

医疗支出不断增加：随着医疗成本的上升，尤其是在开发中国家，医疗机构能够负担更先进的技术，例如骨骼密度。医疗基础设施的成长和医疗服务的便利性推动了市场的扩张。

慢性病的诊断意义：骨骼密度评估对于检测骨质疏鬆症和评估糖尿病、类风湿性关节炎、慢性肾臟病等长期疾病的骨骼健康至关重要。骨骼密度测量在各种慢性疾病的诊断和治疗中的应用越来越多，这刺激了市场扩张。

医疗保健领域的技术整合：将骨质密度检测设备与影像存檔和通讯系统 (PACS) 以及电子健康记录(EHR) 集成，可以帮助医疗机构改善患者照护并提高工作流程效率。这种整合将促进骨质密度检测设备在医疗机构和诊断实验室中的应用。

鼓励保险覆盖和报销政策：这些针对骨骼密度测试的政策将奖励医疗保健提供者提供这些治疗，并分配资金用于购买骨质密度检测设备，从而促进市场扩张。

主要问题

高成本：骨质密度检测设备的购买、维护和使用成本高。高成本使其难以在规模较小的医疗机构和市场中运行，从而限制了其市场渗透率。

报销规定有限：不同地区的骨骼密度测试报销规定可能不均衡或有限，这可能会影响患者的经济负担并减少对骨质密度检测设备的需求。

技术挑战：儘管骨骼密度测量技术取得了重大进步，但准确性、可靠性和易用性问题可能会限制其广泛应用。

来自替代技术的竞争：骨骼密度市场检测法面临其他提供类似或附加资讯的显像模式和诊断技术的竞争，例如电脑断层扫描和超音波。

监管障碍：严格的医疗设备法规可能会阻碍骨质密度检测设备的升级和新型产品的推出，从而阻碍市场扩张。

获取途径和认知度有限：缺乏对骨质疏鬆症和骨骼密度测试重要性的认识可能会减少某些地区和某些人群对骨质密度检测设备的需求。

经济因素：医疗成本的下降或上升可能会影响人们和医疗机构的购买力，导致对骨质密度检测设备的投资减少。

病人担忧：由于担心辐射暴露和检查过程中的不适，患者不愿意接受骨骼密度测试，这可能会影响对骨质密度检测设备的需求。

主要趋势

老龄人口增加和骨质疏鬆症风险增加：全球人口老化导致骨质疏鬆症盛行率上升，推动了对用于诊断和监测的骨质密度检测设备的需求。

技术进步和多重模式成像：DEXA 技术的进步、与数检测器的整合以及对外周定量 CT（pQCT）多重模式成像的探索正在提高准确性和效率，并提供更全面的骨骼健康评估。

早期诊断和疾病管理的应用日益广泛：骨质疏鬆症的早期发现和介入至关重要。骨质密度检测设备越来越多地用于预防保健和监测治疗效果。

专注于携带式和家用骨质密度检测设备：携带式和家用骨骼密度因其便利性以及更广泛的患者群体（尤其是高危险群）的潜在可及性而获得支持。

提高意识和筛检计画：提高大众对骨质疏鬆症的认识和针对骨骼健康筛检计画的措施正在对市场产生积极影响。

报销政策和成本效益分析：报销政策和成本效益分析是影响医院和诊所是否采用骨质密度检测设备的重要因素。

新兴市场和区域成长潜力：由于人口老化和医疗保健支出的增加，骨质密度检测设备市场预计将在中国和印度等新兴经济体中显着成长。

资料安全和与电子健康记录的整合：重视资料安全以及骨质密度检测设备资料与电子健康记录的无缝整合变得越来越重要。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

骨质密度检测设备市场：依技术

• 中轴骨骨密度仪（DXA）
• 周边骨矿物质密度分析（pDXA）
• 定量超音波（QUS）

第五章骨质密度检测设备市场（依最终用户）

• 医院
• 专科诊所
• 影像中心
• 其他的

第六章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第七章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第八章 竞争态势

• 主要企业
• 市场占有率分析

第九章 公司简介

• GE Healthcare
• Hologic Inc.
• Siemens Healthineers
• Swissray Global Healthcare Holding Ltd.
• BeamMed Ltd.
• Osteosys Co., Ltd.
• Diagnostic Medical Systems Group（DMS）
• Medonica Co. Ltd.
• CompuMed, Inc.
• Lone Oak Medical Technologies LLC

第十章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十一章 市场展望 附录

• 简称列表
• 来源和参考文献

Bone Densitometer Market Size And Forecast

Bone Densitometer Market size was valued at USD 284.8 Million in 2024 and is projected to reach USD 398.48 Million by 2032, growing at a CAGR of 4.73 % from 2026 to 2032.

A bone densitometer is a specialized medical device used to measure bone mineral density (BMD), reflecting the amount of mineral content (primarily calcium) per unit volume of bone.

It employs dual-energy X-ray absorptiometry (DXA), emitting two low-dose X-ray beams with differing energy levels. Bone tissue absorbs these beams differently than soft tissue, allowing for precise BMD measurement.

Bone densitometers are primarily utilized for, diagnosing osteoporosis, characterized by low BMD and increased fracture risk, monitoring the efficacy of osteoporosis treatments, and assessing fracture risk in individuals with bone-weakening conditions.

During a Bone Densitometry scan, the patient lies on a table while the scanner arm passes over the specific body part being examined. The procedure is non-invasive and painless, taking about 10 to 30 minutes depending on the number of sites scanned.

Common measurement sites for Bone Densitometry include the spine (lumbar vertebrae), hip (femoral neck and total hip), and forearm (radius). These sites are chosen because they are prone to fractures in osteoporosis and provide accurate readings of bone density.

Bone Densitometry is commonly used for postmenopausal women, who are at higher risk for osteoporosis, older adults to assess general bone health and fracture risk, and individuals with certain medical conditions or on medications that affect bone density.

Global Bone Densitometer Market Dynamics

The key market dynamics that are shaping the global bone densitometer market include:

Key Market Drivers

Growing Osteoporosis Prevalence: Osteoporosis is a serious health issue, especially for the elderly population. The need for bone densitometers for early diagnosis and monitoring is being driven by the rising prevalence of osteoporosis and related bone ailments as the world's population ages.

Technological Developments: The accuracy and efficiency of bone density measurements are improved by developments in bone densitometry technology, such as the creation of portable, high-resolution instruments. The healthcare industry is growing because of these technological improvements, which draw in providers and motivate them to spend money on new equipment.

Growing Awareness and Screening Programmes: The need for bone densitometry screening is driven by growing awareness of bone health and the significance of early bone problem detection. The use of bone densitometers for preventive healthcare is facilitated by government programmes, health campaigns, and improved patient education.

Growing Older Population: Osteoporosis and osteopenia are two bone-related illnesses that are more common in the ageing population. The need for bone densitometry tools to evaluate and manage bone health in the senior population is rising in tandem with the worldwide ageing population.

Growing Healthcare Expenditure: As healthcare costs rise, especially in developing nations, medical facilities can purchase more sophisticated technology, such as bone densitometers. Market expansion is facilitated by the growing healthcare infrastructure and the ease of access to healthcare services.

Diagnostic Significance in Chronic Illnesses: Bone density evaluations are essential for detecting osteoporosis as well as evaluating the health of the bones in long-term ailments such as diabetes, rheumatoid arthritis, and chronic kidney disease. Market expansion is fueled by the growing use of bone densitometry in the diagnosis and treatment of a range of chronic illnesses.

Technological Integration in Healthcare: By integrating bone densitometry equipment with picture archiving and communication systems (PACS) and electronic health records (EHRs), healthcare institutions can improve patient care and workflow efficiency. The use of bone densitometers in medical facilities and diagnostic labs is encouraged by this integration.

Encouraging Insurance Coverage and Reimbursement Policies: These Policies for bone densitometry examinations incentivize healthcare providers to deliver these treatments and allocate funds towards purchasing bone densitometry equipment, thereby driving market expansion.

Key Challenges:

High Cost: The purchase, upkeep, and use of bone densitometers can be costly. Smaller healthcare facilities or those in developing countries may find it prohibitive to operate due to this high cost, which would restrict market penetration.

Limited Reimbursement Regulations: Reimbursement regulations for bone density testing may be uneven or limited in various regions, which may impact patient affordability and consequently lower demand for bone densitometers.

Technological Difficulties: Although bone densitometry technology has come a long way, adoption rates may still be impacted by issues with accuracy, dependability, and usability.

Rivalry from Alternative Technologies: There may be rivalry in the market for bone densitometry from other imaging modalities or diagnostic procedures that offer comparable or additional information. Examples of these procedures include CT scans and ultrasounds.

Regulatory Obstacles: Tight regulations pertaining to medical equipment may impede the release of upgraded or new bone densitometer models, hence impeding market expansion.

Limited Access and Awareness: There may be a decreased demand for bone densitometers in specific areas or among certain demographic groups due to a lack of knowledge about osteoporosis and the significance of bone density testing.

Economic Factors: Declines or spikes in healthcare costs can affect people's and healthcare facilities' purchasing power, which can result in a decrease in the amount of money invested in bone densitometry equipment.

Patient Concerns: The demand for bone densitometers may be impacted by patients' reluctance to undertake bone density testing because they are worried about radiation exposure or discomfort during the operation.

Key Trends:

Rising Geriatric Population and Increased Osteoporosis Risk: An aging population globally leads to a higher prevalence of osteoporosis, driving the demand for bone densitometers for diagnosis and monitoring.

Technological Advancements and Multi-Modality Imaging: Advancements in DEXA technology, integration with digital detectors, and exploration of multi-modality imaging with peripheral quantitative CT (pQCT) are increasing accuracy, and efficiency, and offering more comprehensive bone health assessment.

Growing Adoption in Early Diagnosis and Disease Management: Early detection and intervention for osteoporosis are crucial. Bone densitometers are becoming increasingly used for preventive care and monitoring treatment response.

Focus on Portable and Home-Based Bone Densitometers: Portable and home-based bone densitometers are gaining traction due to their convenience and potential for wider patient access, particularly for at-risk populations.

Increasing Awareness and Screening Programs: Growing public awareness about osteoporosis and initiatives for bone health screening programs are positively impacting the market.

Reimbursement Policies and Cost-Effectiveness Analysis: Reimbursement policies and cost-effectiveness analyses are crucial factors influencing hospital and clinic decisions regarding bone densitometer adoption.

Emerging Markets and Regional Growth Potential: The Bone Densitometer Market is expected to see significant growth in emerging economies like China and India due to their aging populations and rising healthcare expenditure.

Data Security and Integration with Electronic Health Records: Focus on data security and seamless integration of bone densitometer data with electronic health records is becoming increasingly important.

Global Bone Densitometer Market Regional Analysis

Here is a more detailed regional analysis of the global bone densitometer market:

North America

North America is significantly dominating the bone densitometer market and is expected to continue its growth throughout the forecast period.

North America dominates the worldwide Bone Densitometer market in terms of both size and revenue. This dominance is due to increased healthcare spending, superior medical infrastructure, and early adoption of innovative medical technologies.

The region benefits from ongoing technical advances in medical imaging and diagnostics, which drive demand for improved bone densitometer systems.

North America is home to many of the world's main manufacturers of bone densitometers, which contributes to the region's dominant position. To preserve market leadership, these organizations prioritize innovation and product development.

In North America, there is a significant emphasis on preventative healthcare and osteoporosis screening programs, which drives up demand for Bone Densitometers for early detection and treatment.

A well-established regulatory system protects product safety and efficacy, giving healthcare practitioners and patients confidence in using Bone Densitometer technology.

North America is a key location for medical technology research and development, which promotes ongoing innovation in Bone Densitometer systems. This innovation fuels market growth and ensures the region's dominance.

The region's significant healthcare expenditure supports advanced diagnostic technology such as bone densitometers, assuring widespread availability in clinical settings.

North America has a well-established healthcare system, with many healthcare facilities outfitted with advanced diagnostic equipment, including Bone Densitometers.

Asia Pacific

Asia Pacific is anticipated to be the fastest-growing region in the bone densitometer market. Economic development, an aging population, and an increased frequency of osteoporosis and related disorders are all contributing to Asia Pacific's rapid growth in healthcare spending.

Countries such as China, India, and Japan are experiencing rapid growth in healthcare infrastructure and medical device usage, including Bone Densitometers.

Governments in Asia Pacific are increasingly focusing on improving healthcare accessibility and quality, including investments in innovative medical equipment like bone densitometers.

Healthcare practitioners and consumers are becoming more aware of the importance of bone health and early detection of osteoporosis, which is driving up demand for Bone Densitometer devices.

Rapid urbanization and economic expansion in Asia Pacific have resulted in enhanced healthcare infrastructure and higher adoption rates of modern medical technologies such as bone densitometers.

The region's aging population, together with higher life expectancy, is pushing up demand for Bone Densitometers to effectively manage osteoporosis and related disorders.

Governments across the Asia Pacific are investing in healthcare infrastructure development and programs to improve healthcare access, including the purchase of diagnostic equipment such as bone densitometers.

Local and foreign manufacturers are producing technologically improved Bone Densitometer systems designed specifically for Asia Pacific markets, increasing acceptance rates.

Global Bone Densitometer Market: Segmentation Analysis

The Global Bone Densitometer Market is segmented based on Technology, End-User, And Geography.

Bone Densitometer Market, By Technology

• Axial Bone Densitometry (DXA)
• Peripheral Bone Densitometry (pDXA)
• Quantitative Ultrasound (QUS)

Based on Technology, the market is bifurcated into Axial Bone Densitometry (DXA), Peripheral Bone Densitometry (pDXA), and Quantitative Ultrasound (QUS). Axial Bone Densitometry (DXA) dominates the Bone Densitometer market because to its high precision and dependability in detecting bone mineral density at important areas such as the spine and hip, which are particularly vulnerable to osteoporotic fractures. Its broad use in clinical settings for osteoporosis diagnosis and fracture risk assessment, together with its capacity to give complete and exact data, strengthens its position as the industry leader. Furthermore, ongoing technical improvements and endorsements from major health organizations increase its use and desirability among healthcare providers.

Bone Densitometer Market, By End User

• Hospitals
• Specialty Clinics
• Imaging Centers

Based on End Users, the market is bifurcated into Hospitals, Specialty Clinics, and Imaging Centers. Hospitals lead the Bone Densitometer market because of their enormous infrastructure and capacity to provide comprehensive diagnostic services, such as advanced imaging technologies. They are frequently outfitted with cutting-edge bone densitometry technology, such as DXA machines, which are critical for detecting and monitoring osteoporosis and other bone-related diseases. The large number of patients in hospitals, together with their ability to handle complex situations and provide integrated treatment, ensures a consistent need for bone densitometry services. Furthermore, the presence of specialist departments and competent healthcare personnel improves the reliability and accuracy of bone density evaluations, bolstering hospitals' market-leading position.

Bone Densitometer Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the Global Bone Densitometer Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is significantly dominating the bone densitometer market and is expected to continue its growth throughout the forecast period, owing to several variables. North America dominates the worldwide Bone Densitometer market in terms of both size and revenue. This dominance is due to increased healthcare spending, superior medical infrastructure, and early adoption of innovative medical technologies. The region benefits from ongoing technical advances in medical imaging and diagnostics, which drive demand for improved bone densitometer systems.

Key Players

• The "Global Bone Densitometer Market" study report will provide valuable insight emphasizing the global market. The major players in the market are GE Healthcare, Hologic Inc., DMS Imaging, Swissray International Inc., Osteometer Meditech Inc., Echolight S.p.A., Medonica Co. Ltd, Hitachi Ltd., Siemens Healthineers, and Canon Medical Systems Corporation

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In March 2023, GE Healthcare announced the launch of an updated version of their Lunar iDXA system, featuring enhanced software capabilities to improve diagnostic accuracy and patient throughput.
• In April 2022, Hologic Inc. expanded its product line with the introduction of the Horizon DXA system, designed to offer advanced imaging capabilities for comprehensive bone health assessment.
• In February 2023, DMS Imaging unveiled a new series of portable bone densitometers aimed at increasing accessibility in rural and remote healthcare settings, enhancing the ability to diagnose and treat osteoporosis.
• In January 2023, Swissray International Inc. launched their new Digital Radiography (DR) solutions that integrate bone densitometry capabilities, streamlining diagnostic processes in clinical settings.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Bone Densitometer Market, By technology

• Axial bone densitometry (DXA)
• Peripheral bone densitometry (pDXA)
• Quantitative ultrasound (QUS)

5. Bone Densitometer Market, By end-user

• Hospitals
• Specialty clinics
• Imaging centers
• Other end-users

6. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

7. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

8. Competitive Landscape

• Key Players
• Market Share Analysis

9. Company Profiles

• GE Healthcare
• Hologic Inc.
• Siemens Healthineers
• Swissray Global Healthcare Holding Ltd.
• BeamMed Ltd.
• Osteosys Co., Ltd.
• Diagnostic Medical Systems Group (DMS)
• Medonica Co. Ltd.
• CompuMed, Inc.
• Lone Oak Medical Technologies LLC

10. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

11. Appendix

• List of Abbreviations
• Sources and References